Notice To Change Catalog of Federal Domestic Assistance (CFDA) Number, 50223 [2011-20507]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 156 / Friday, August 12, 2011 / Notices
NICEATM–ICCVAM Web site (https://
iccvam.niehs.nih.gov).
Application Selection Process
References
WHO. 2010. Rabies vaccines: WHO
Position paper. Weekly Epidemiological
Record 85(32):309–320.
Dated: August 3, 2011.
John R. Bucher,
Associate Director, National Toxicology
Program.
[FR Doc. 2011–20540 Filed 8–11–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice To Change Catalog of Federal
Domestic Assistance (CFDA) Number
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
This notice provides public
announcement of CDC’s intent to award
two awards to eligible applicants of
State or Territorial Public Health
Newborn Bloodspot Screening
Programs. These activities are proposed
by the above-mentioned grantees in
their FY 2011 applications submitted
under funding opportunity CDC–RFA–
EH11–001, ‘‘Program to Support New
Implementation of State or Territorial
Public Health Laboratory Capacity for
Newborn Bloodspot Screening of Severe
Combined Immune Deficiency (SCID)
(U01), ’’ Catalog of Federal Domestic
Assistance Number (CFDA): 93.070.
Approximately $900,000 in funding will
be awarded to the grantees for the
implementation of newborn screening
for SCID.
Accordingly, CDC adds the following
information to the previously published
funding opportunity announcement of
EH11–001:
SUMMARY:
Authority: Authorized under Section 301
of the Public Health Service Act, [42 U.S.C.
241], as amended.
CFDA #: 93.070 Environmental Public
Health Emergency Response.
mstockstill on DSK4VPTVN1PROD with NOTICES
Award Information
Type of Award: New Competing
Cooperative Agreement.
Approximate Total Current Fiscal
Year ACA Funding: $900,000.
Anticipated Number of Awards: 2.
Fiscal Year Funds: 2011.
Anticipated Award Date: September
1, 2011.
VerDate Mar<15>2010
16:37 Aug 11, 2011
Jkt 223001
Funding will be awarded to
applicants based on results from the
peer review panel ranking
recommendations.
Funding Authority
CDC will add the authority to that
which is reflected in the published
Funding Opportunity CDC–RFA–EH11–
001. The revised funding authority
language will read:
—Authorized under Section 301 of the
Public Health Service Act, [42 U.S.C.
241], as amended.
DATES: The effective date for this action
is the date of publication of this Notice
and remains in effect until the
expiration of the project period of the
funded applications.
FOR FURTHER INFORMATION CONTACT: Beth
Gardner, Extramural Team Lead,
National Center for Environmental
Health, Centers for Disease Control and
Prevention, 4770 Buford Hwy., Atlanta,
GA 30341, telephone (770) 488–0572, email Bgardner@cdc.gov.
SUPPLEMENTARY INFORMATION: None.
Dated: August 3, 2011.
James Stephens,
Director of the Office of Science Quality,
Centers for Disease Control and Prevention.
[FR Doc. 2011–20507 Filed 8–11–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 76 FR 47189–47190,
dated August 4, 2011) is amended to
reflect the reorganization of the Center
for Global Health, Centers for Disease
Control and Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows: After the title and functional
statements for the Division of Global
Disease Detection and Emergency
Response (CWJ), insert the following:
Global Immunization Division (CWK).
The Global Immunization Division
(GID) protects the health of Americans
and global citizens by preventing
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
50223
disease, disability, and death worldwide
from vaccine-preventable diseases. In
carrying out its mission, GID: (1)
Provides national leadership and
coordination of the CGH efforts to
eradicate polio, control or eliminate
measles, strengthen routine
immunization programs, introduce new
and under-utilized vaccines, and
promote safe injection practices, in
collaboration with international
organizations and CDC Centers/
Institute/Offices; (2) provides short- and
long-term consultation and technical
assistance to the WHO, UNICEF, and
foreign countries involved in global
immunization activities and participates
in international advisory group
meetings on immunization issues; (3)
administers grants to WHO, Pan
American Health Organization (PAHO),
UNICEF, and other international
partners as appropriate for the provision
of technical, programmatic, and
laboratory support, and vaccine
procurement for initiatives to support
global immunization targets; (4) designs
and participates in international
research, monitoring, and evaluation
projects to increase the effectiveness of
immunization strategies as may be
developed; (5) develops strategies to
improve the technical skills and
problem-solving abilities of program
managers and health care workers in
other countries; (6) refines strategies
developed for the eradication or control
of vaccine-preventable diseases in the
Western Hemisphere for
implementation in other parts of the
world; (7) assists other countries, WHO,
and other partners to improve
surveillance for polio, measles, and
other vaccine preventable diseases
(VPDs); (8) prepares articles based on
findings for publication in international
professional journals and presentation
at international conferences; (9)
collaborates with other countries, WHO,
UNICEF, and advocacy groups to ensure
the availability of sufficient funds to
purchase an adequate supply of polio,
measles, and other vaccines, and funds
for technical support for use in
eradication and control efforts; and (10)
provides technical and operational
leadership for CDC’s activities in
support of the immunization initiatives
such as Global Alliance for Vaccines
and Immunization and the Global
Immunization Vision and Strategies.
Office of the Director (CWK1). (1)
Provides leadership, management, and
oversight for all division activities; (2)
provides coordination of budgeting and
liaison with CGH, and FMO on budget
and spending; (3) provides coordination
and oversight of the division’s
E:\FR\FM\12AUN1.SGM
12AUN1
]]>Agencies
[Federal Register Volume 76, Number 156 (Friday, August 12, 2011)]
[Notices]
[Page 50223]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-20507]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice To Change Catalog of Federal Domestic Assistance (CFDA)
Number
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice provides public announcement of CDC's intent to
award two awards to eligible applicants of State or Territorial Public
Health Newborn Bloodspot Screening Programs. These activities are
proposed by the above-mentioned grantees in their FY 2011 applications
submitted under funding opportunity CDC-RFA-EH11-001, ``Program to
Support New Implementation of State or Territorial Public Health
Laboratory Capacity for Newborn Bloodspot Screening of Severe Combined
Immune Deficiency (SCID) (U01), '' Catalog of Federal Domestic
Assistance Number (CFDA): 93.070. Approximately $900,000 in funding
will be awarded to the grantees for the implementation of newborn
screening for SCID.
Accordingly, CDC adds the following information to the previously
published funding opportunity announcement of EH11-001:
Authority: Authorized under Section 301 of the Public Health
Service Act, [42 U.S.C. 241], as amended.
CFDA : 93.070 Environmental Public Health Emergency
Response.
Award Information
Type of Award: New Competing Cooperative Agreement.
Approximate Total Current Fiscal Year ACA Funding: $900,000.
Anticipated Number of Awards: 2.
Fiscal Year Funds: 2011.
Anticipated Award Date: September 1, 2011.
Application Selection Process
Funding will be awarded to applicants based on results from the
peer review panel ranking recommendations.
Funding Authority
CDC will add the authority to that which is reflected in the
published Funding Opportunity CDC-RFA-EH11-001. The revised funding
authority language will read:
--Authorized under Section 301 of the Public Health Service Act, [42
U.S.C. 241], as amended.
DATES: The effective date for this action is the date of publication of
this Notice and remains in effect until the expiration of the project
period of the funded applications.
FOR FURTHER INFORMATION CONTACT: Beth Gardner, Extramural Team Lead,
National Center for Environmental Health, Centers for Disease Control
and Prevention, 4770 Buford Hwy., Atlanta, GA 30341, telephone (770)
488-0572, e-mail Bgardner@cdc.gov.
SUPPLEMENTARY INFORMATION: None.
Dated: August 3, 2011.
James Stephens,
Director of the Office of Science Quality, Centers for Disease Control
and Prevention.
[FR Doc. 2011-20507 Filed 8-11-11; 8:45 am]
BILLING CODE 4163-18-P
